✦ LIBER ✦

Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck

✍ Scribed by Andrew J. Sykes; Nick J. Slevin; Robert H. MacDougall; Janet A.D. Ironside; Kathleen L. Mais

Book ID: 118496232
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 86 KB
Volume: 71
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2004.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stereotactic Body Radiotherapy for Recur

Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial

✍ Dwight E. Heron; Robert L. Ferris; Michalis Karamouzis; Regiane S. Andrade; Erin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 972 KB

Phase II study of concurrent chemoradiot

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck

✍ Kim, J G; Sohn, S K; Kim, D H; Baek, J H; Jeon, S B; Chae, Y S; Lee, K B; Park, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

Phase III Study of Preoperative Concurre

Phase III Study of Preoperative Concurrent Chemoradiotherapy Compared with Preoperative Radiotherapy Alone in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

✍ J. Yi; G. Li; X. Huang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Phase I and initial phase II results fro

Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

✍ David L. Schwartz; R. Bruce Montgomery; Bevan Yueh; Michael Donahue; Yoshimi Anz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract ## BACKGROUND The current Phase I/II study assessed induction docetaxel/carboplatin given weekly for 4 weeks, followed by weekly docetaxel/carboplatin and concomitant boost radiotherapy (CB‐XRT) for locally advanced head and neck squamous cell carcinoma. ## METHODS Twenty patients wi

Phase II trial of cisplatin and capecita

Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors

✍ Hitt, R; Jimeno, A; Rodríguez-Pinilla, M; Rodríguez-Peralto, J L; Millán, J M; L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

O14 Phase II study of concurrent radioth

O14 Phase II study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data

✍ Specenier, P.; Van den Weyngaert, D.; Van Laer, C.; Weyzer, J.; Van den Brande, 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 48 KB